UPCOMING SESSIONS in ET
Fri, Nov 20, 2026
6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness Hamide Eygoren Register
UPCOMING SESSIONS in ET
Fri, Nov 20, 2026 · 6:00 – 7:00 AM Bangkok
Sadness, Anger and Fear: Coping With the Emotions of Illness
Hamide Eygoren
Register
View all sessions

Eligibility criteria for clinical trials in AL amyloidosis result in exclusion of nearly half of real‐world patients

Immunoglobulin light chain (AL) amyloidosis is a rare and potentially

life‐threatening disorder characterized by the deposition of

misfolded, toxic immunoglobulin light chains in organs and tissues,

typically produced by a plasma cell (PC) clone.

1

The deposition of

amyloidogenic light chains disrupts tissue structure, leading to organ

dysfunction with a wide range of symptoms and clinical

manifestations